We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Transfection Reagents

NanoLucProteinStability-280x90ViaFect Transfect Reagent. Develop More Viable Assays. Request a Sample Today.

Need Assistance? Chat

Build a More Viable Assay

When performing transfection-based experiments, the biology of the cells to be analyzed is critical. ViaFect™ Transfection Reagent allows high-efficiency transfection of a wide range of cell types without compromising cell viability, allowing you to design a more relevant assay.

Featured Products

ViaFect™ Transfection Reagent

Generate more relevant data with efficient transfection of your optimal cell line without compromising cell viability.

FuGENE® 6 Transfection Reagent

FuGENE® 6 offers proven performance cited in thousands of scientific papers and used in hundreds of cell lines. The novel non-liposomal formulation offers high efficiency transfection of DNA with minimal toxicity.

FuGENE® HD Transfection Reagent

Transfect DNA into a wide variety of cell lines with high efficiency and low toxicity! There is no need to remove serum or culture medium after introducing the reagent:DNA complex.

TransFast™ Transfection Reagent

Spend less time optimizing transfections especially for primary cell cultures requiring continuous exposure to serum.

Featured Resources

pubhub_fr Reverse Transfection Using FuGENE® 6 and FuGENE® HD

In this article, we tested the ability of FuGENE® 6 and FuGENE® HD to “reverse” transfect three cell lines and monitored efficiency and toxicity using the ONE-Glo™ + Tox Luciferase Reporter and Cell Viability Assay.

Tools_fr FuGENE® HD Optimization Analysis

This simple data analysis tool helps determine optimal transfection conditions for the system being tested.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.